#abvcbiopharma

  1. US Stocks Down; Chicago Fed National Activity Index Falls In October

    By Lisa Levin U.S. stocks traded lower this morning, with the Dow Jones index falling more than 80 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.25% to 35,062.20 while the NASDAQ fell 0.54% to 14,209.12. The S&P 500 also fell, dropping, 0.31% to 4,5
  2. ABVC Biopharma (NASDAQ: ABVC) Inks Major Licensing Agreement with Xinnovation Therapeutics for ABV-1504 and ABV-1505 ABVC Biopharma, Inc. has signed an exclusive licensing term sheet with Xinnovation Therapeutics Co., Ltd for the development and distribution of ABV-1504 and ABV-15
  3. US Stocks Mixed; Pfizer Earnings Beat Views

    By Lisa Levin U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to 14,264.52. The S&P 500, also fell, dropping, 0.32% to 4,574.50. Check T
  4. Stocks That Hit 52-Week Lows On Monday

    By Benzinga Insights On Monday, 27 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was Apellis Pharmaceuticals (NASDAQ: APLS ) . Esports Entertainment (NASDAQ: GMBL ) was the smallest company by market c
  5. Why ABVC Biopharma Stock Is Roaring Higher

    By Erica Kollmann ABVC BioPharma, Inc. (NASDAQ: ABVC ) shares are roaring higher Wednesday after the company announced a partnership with Zhonghui United Technology Group Co., Ltd. The Details: ABVC BioPharma has announced a partnership with Zhonghui United Technology Group aimed at